1. Home
  2. Analysis
  3. Glucagon
  4. Cleocin

Glucagon and Cleocin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glucagon and Cleocin. Common interactions include abscess among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people who take Glucagon and Cleocin have. It is created by eHealthMe based on reports of 9 people who take Glucagon and Cleocin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

9 people who take Glucagon and Cleocin together, and have interactions are studied.

What is Glucagon?

Glucagon has active ingredients of glucagon hydrochloride. eHealthMe is studying from 3,519 Glucagon users for its effectiveness, alternative drugs and more.

What is Cleocin?

Cleocin has active ingredients of clindamycin phosphate. It is often used in infection. eHealthMe is studying from 3,768 Cleocin users for its effectiveness, alternative drugs and more.

Number of Glucagon and Cleocin reports submitted per year:

Glucagon and Cleocin drug interactions.

Common Glucagon and Cleocin drug interactions by gender *:

female:

  1. Abscess
  2. Cellulitis
  3. Sepsis
  4. Septic shock

male:

  1. Chronic kidney disease
  2. Necrotising fasciitis
  3. Hypertension
  4. Hypoglycaemia
  5. Nephrogenic anaemia
  6. Perineal abscess
  7. Respiratory failure
  8. Sepsis
  9. Wound infection
  10. Abscess limb

Common Glucagon and Cleocin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Nephrogenic anaemia
  3. Renal failure

40-49:

  1. Necrotising fasciitis
  2. Scrotal abscess
  3. Actinic keratosis
  4. Arteriosclerosis
  5. Cardiac failure congestive
  6. Chapped lips
  7. Chronic kidney disease
  8. Colon cancer
  9. Gangrene
  10. Hypertension

50-59:

  1. Chapped lips
  2. Colon cancer
  3. Gangrene
  4. Hypertension
  5. Hypoglycaemia
  6. Neutrophil count decreased
  7. Perineal abscess
  8. Renal failure
  9. Renal tubular necrosis
  10. Respiratory failure

60+:

  1. Abscess
  2. Cellulitis
  3. Sepsis
  4. Septic shock

* Approximation only. Some reports may have incomplete information.

Do you take Glucagon and Cleocin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Glucagon and Cleocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Glucagon side effects:

Browse all side effects of Glucagon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cleocin side effects:

Browse all side effects of Cleocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Glucagon interactions:

Browse all interactions between Glucagon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cleocin interactions:

Browse all interactions between Cleocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on glucagon hydrochloride and clindamycin phosphate (the active ingredients of Glucagon and Cleocin, respectively), and Glucagon and Cleocin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Glucagon and Cleocin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.